Search results
4 days ago · Number of syringes or pens (each 50 mg syringe or pen is 1 mL) Usual dosing is 1 syringe or pen – 7-day supply. evolocumab (Repatha™) 02459779. Number of syringes (420 mg/3.5 mL pre-filled cartridge) filgrastim (Grastofil ®) 300 µg/0.5 mL. 480 µg/0.8 mL. single-use pre-filled syringe.
3 days ago · McKesson Corp. research and ratings by Barron's. View MCK revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.
3 days ago · McKesson Corporation is a provider of diversified healthcare services. The Company is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States.
4 days ago · Updated Jun 24, 2024 04:00 PM ET. After-Market: $607.45 -0.36 (-0.06%) 7:58 PM ET. Add to portfolio. Zacks Rank:
5 days ago · We’d like to share more about how we work and what drives our day-to-day business. Read about McKesson Corp (MCK:XNYS) stock and today's latest news and financial updates.
4 days ago · McKesson Revenue. In the fiscal year ending March 31, 2024, McKesson had annual revenue of $308.95B with 11.65% growth. Revenue in the quarter ending March 31, 2024 was $76.36B with 10.80% year-over-year growth. Revenue (ttm)
5 days ago · Corporate Overview. McKesson Corporation is a global leader in healthcare and dedicated to improving care in every setting — one product, one partner, one patient at a time. We partner with care providers, pharmacies, manufacturers and more to safely deliver the right medicines, medical products and healthcare services to the patients who ...
